Memory Support System for Chinese American older adults with mild cognitive impairment
Tests a memory support program in older Chinese Americans with mild cognitive impairment.
Key facts
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Memory Support System for Older Chinese Americans With Mild Cognitive Impairment
- Status
- Recruiting
- People taking part
- 7 people, planned
- Started
- 29 Jul 2025
- Planned end
- May 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Memory Support System
- Brain Health Education
- Record updated
- 6 November 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Chinese American adults aged 55 and above with mild cognitive impairment (mild memory and thinking problems). They mainly speak Cantonese or Mandarin.
- Age
- 55 years and above
- Sex
- All sexes
- Disease stage
- Mild cognitive impairment (MCI), confirmed by a documented clinical assessment and/or research diagnostic criteria.
- Earlier treatment
- People can join if they take no prescribed memory medicines, or have taken them at a stable dose for the last 3 months.
Main reasons for not taking part
- Any serious brain or nerve disease that would affect taking part in the trial
- A psychiatric disorder (DSM 5 criteria) in the last 12 months
- A reading or writing disability that would get in the way of the training
- Taking part in another related clinical trial at the same time
- No one in regular contact who can act as a study partner
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- self-identify as Chinese American
- age 55 and above
- a diagnosis of MCI as confirmed through documented clinical assessment and/or research-based diagnostic criteria
- predominantly Cantonese- or Mandarin-speaking
- able to read and write in Chinese
- visual and auditory acuity adequate for cognitive testing
- willing to complete the assessment measures
- having someone in regular contact to serve as a study partner/informant
- absence or stable use of prescribed memory-enhancing medications within the last 3 months
Who cannot take part
- concurrent participation in another relevant clinical trial
- any significant neurologic disease that would impact their participation and completion of the trial
- history of psychiatry disorder (DSM 5 criteria) within the last 12 months
- history of reading or writing disability sufficient to interfere with MSS training; or
This trial is currently available in United States.
- Li Lab, Icahn School of Medicine at Mount SinaiNew York, United StatesContact: Shreya Upendra, MATaking people
About the trial
What the trial wants to find out
The Memory Support System (MSS) from the Healthy Action to Benefit Independence \& Thinking® (HABIT) Program is an evidence-based, non-pharmacological intervention for mild cognitive impairment (MCI). Despite the clinical benefits and feasibility, the MSS was primarily developed and used with non-Hispanic White, English-speaking adults. Racial/ethnic minority groups are chronically under-enrolled in clinical trials for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) due to lack of linguistically and culturally appropriate adaptation of assessment measures and intervention protocols. The purpose of this research study is to examine whether the MSS from HABIT can help Chinese American older adults with mild thinking and memory problems. Target recruitment is 60 Chinese American adults who are primarily Mandarin- (n=30) and Cantonese-speaking (n=30). Forty participants will participate in the trainer-led day planner training and 20 will participate in self-study of the day planner and receive brain health education. Each participant will also be asked to identify a study partner to participate with them.
The 2 groups in the trial
- MSS Intervention GroupTreatment being tested
10-session MSS Training Workbook. Additional sessions beyond the standard 10 sessions can be added up to a maximum of 15 total sessions.
Treatment: Memory Support System
- Brain Health Education Control GroupExisting treatment, for comparison
10 session Brain Health Education. Additional sessions beyond the standard 10 sessions can be added up to a maximum of 15 total sessions.
Treatment: Brain Health Education
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Pilot of Memory Support System for Older Chinese Americans With Mild Cognitive Impairment
- Plain-language title
- Memory Support System for Chinese American older adults with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 6 November 2025